Executive summary. Serialization makes a package distinguishable. Whether that helps depends on how well the identifier stays attached to the right package and the right transaction.
Definition
Enhanced drug distribution security is the DSCSA framework for interoperable electronic product tracing and package-level product identifiers.
What an identifier actually asserts
A product identifier means something only while it stays associated with the correct package and transaction. Validate its structure, preserve the source of the assertion, and never substitute an incomplete identifier silently.
Package-level data does not settle legal or operational disposition. Define how the team handles records that arrive incomplete, duplicated, or inconsistent.
Exchange needs an exception path
Interoperable exchange moves traceability information between trading partners electronically. It does not guarantee that every received record is usable. A receiving workflow should record validation results and raise a reviewable exception when data cannot be associated.
Treat transmission as one step. The work finishes when the organization decides whether the information supports the transaction it is attached to.
Frequently asked questions
Is a barcode scan sufficient evidence of compliant tracing?
A scan captures an identifier. A traceability decision also rests on the associated transaction information, the trading-partner context, and the applicable procedure.
Referenced standards and further reading
- FDA: Enhanced Drug Distribution Security ↗U.S. Food and Drug Administration
Related articles
DSCSA traceability and exception handling →
DSCSA product tracing: the operational record →
Suspect and illegitimate product: designing the response path →